The results are summarized in Table 2 and a representative tumor growth inhibition curves was shown in Fig. 3D and Supplement Fig. S3D, both suggest that CD47hi models may represent better responders to HX009, or CD47 expression could be a positive predicator for HX009 pharmacology. Here, CD47 is linked to neoplasm.